Description Echinacea Purpurea Cichoric Acid 2% [Liquid] The product is intended for laboratory research only and not for human consumption. Available quantities: 33ml Product Information Pubchem CID Echinacea Purpurea Cichoric Acid 2% [Liquid] Peptide purity (HPLC) 98-99% Source Synthetic Form liquid Shelf Life 12-14 months under recommended conditions Handling and Storage of the Compound Echinacea Purpurea Cichoric Acid 2% (liquid) should be stored in a cool, dry place. For optimal stability, refrigerate it between 2°C and 8°C (36°F–46°F) in an airtight container. Overview of Echinacea Purpurea Cichoric Acid 2% Liquid Echinacea purpurea chronic acid 2% liquid is a standardized form of botanical formulation. According to the preclinical studies, it is derived from the purple flower Echincea purpurea. Phytochemical analysis has confirmed that the preparation contains 2% of Cichoric acid, a phenolic compound belonging to the class of caffeic acid derivatives (Dicaffeoyl tartaric acid). Moreover, the liquid extract form, often prepared via aqueous (H₂O) or ethanolic (C₂H₅OH) extraction, provides potentially improved bioavailability, which is important for laboratory evaluation and preclinical research. Working Mechanism of Echinacea purpurea Cichoric Acid 2% Liquid Limited laboratory evidence suggests that Cichoric acid ( C₂₂H₁₈O₁₂ ) may support phagocytic activity. Lab experiments found that Echinacea contains polysaccharides and glycoproteins that activate neutrophils, macrophages, and natural killer cells. All these elements may support immune cell activation pathways in research models. Laboratory studies revealed that Echinacea purpurea Cichoric Acid 2% liquid has demonstrated antioxidant properties in laboratory models. The compound helps in neutralizing reactive oxygen and prevents oxidative damage to lipids, proteins, and DNA. Experimental scientists have found that the compound may downregulate pro-inflammatory cytokines like TNF-α, IL-1β, and IL-6. Moreover, it may increase the expression of anti-inflammatory mediators as per preclinical evidence. Echinacea purpurea Cichoric Acid 2% liquid may decrease inflammatory reactions in laboratory models by regulating signaling pathways like NF-κB and MAPK. Along with a potential mechanism, the compound also has some laboratory observations: Mild stomach upset Nausea Headache Skin rashes Dizziness Throat irritation Choose RCDbio for Echinacea purpurea Cichoric Acid 2% liquid RCDbio provides research chemicals, laboratory-grade extracts, and peptides with third-party testing for quality and purity standards. We aim to be your trusted online source for this compound and other research-grade compounds. In addition, we provide a quick and secure transaction experience to our buyers. Disclaimer Echinacea purpurea chronic acid 2% liquid is intended exclusively for laboratory research purposes. RCDbio products are not intended to diagnose, treat, cure, or prevent any disease. The Food and Drug Administration has not evaluated the statements on our website. By purchasing, you agree to our Terms and Conditions.
